Clinical Trial Update: Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology [NA]

View source ↗

Summary

Clinical trial update for WATCHMAN FLX LAA closure device evaluating its use in atrial fibrillation; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• WATCHMAN FLX

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2022-06-14